CNS Pharmaceuticals, Inc. (CNSP)
5.75
-0.19
(-3.20%)
USD |
NASDAQ |
Sep 09, 16:00
5.75
0.00 (0.00%)
After-Hours: 16:58
CNS Pharmaceuticals Price to Book Value : 0.4617 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.477 |
| September 04, 2026 | 0.4601 |
| September 03, 2026 | 0.4727 |
| September 02, 2026 | 0.4826 |
| September 01, 2026 | 0.4731 |
| August 31, 2026 | 0.4802 |
| August 28, 2026 | 0.4435 |
| August 27, 2026 | 0.443 |
| August 26, 2026 | 0.4368 |
| August 25, 2026 | 0.4657 |
| August 24, 2026 | 0.477 |
| August 21, 2026 | 0.4681 |
| August 20, 2026 | 0.4818 |
| August 19, 2026 | 0.4681 |
| August 18, 2026 | 0.4707 |
| August 17, 2026 | 0.4336 |
| August 14, 2026 | 0.4432 |
| August 13, 2026 | 0.4135 |
| August 12, 2026 | 0.4023 |
| August 11, 2026 | 0.4416 |
| August 10, 2026 | 0.4119 |
| August 07, 2026 | 0.432 |
| August 06, 2026 | 0.4204 |
| August 05, 2026 | 0.4336 |
| August 04, 2026 | 0.4304 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.4649 |
| July 31, 2026 | 0.4671 |
| July 30, 2026 | 0.3894 |
| July 29, 2026 | 0.4015 |
| July 28, 2026 | 0.4071 |
| July 27, 2026 | 0.4071 |
| July 24, 2026 | 0.42 |
| July 23, 2026 | 0.4344 |
| July 22, 2026 | 0.4657 |
| July 21, 2026 | 0.4328 |
| July 20, 2026 | 0.4416 |
| July 17, 2026 | 0.4047 |
| July 16, 2026 | 0.3806 |
| July 15, 2026 | 0.3758 |
| July 14, 2026 | 0.3902 |
| July 13, 2026 | 0.4087 |
| July 10, 2026 | 0.4147 |
| July 09, 2026 | 0.4272 |
| July 08, 2026 | 0.4336 |
| July 07, 2026 | 0.4099 |
| July 06, 2026 | 0.3999 |
| July 02, 2026 | 0.4071 |
| July 01, 2026 | 0.3758 |
| June 30, 2026 | 0.3838 |
| June 29, 2026 | 47.63 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.717 |
| Corcept Therapeutics, Inc. | 17.68 |
| Veru, Inc. | 1.502 |
| Johnson & Johnson | 7.572 |
| Eli Lilly & Co. | 31.24 |
Price to Book Value Related Metrics
| Price | 5.75 |
| Earnings Yield | -410.3% |
| Market Cap | 8.403M |